Baby Safety / Compounds / Levothyroxine

Is Levothyroxine safe for babies and kids?

Context-dependent for kids

(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Levothyroxine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

What is levothyroxine?

The IUPAC name is 2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propionic acid.

Also known as: 2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propionic acid, thyroxine, thyroxin, L Thyroxin beta.

IUPAC name
2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propionic acid
CAS number
51-48-9
Molecular formula
C15H11I4NO4
Molecular weight
776.87 g/mol
SMILES
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N
PubChem CID
5819

Risk for babies

Context-dependent

Pregnancy alters the metabolism and distribution of Levothyroxine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Levothyroxine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

3 regulatory and scientific bodies have classified Levothyroxine. The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA——
EMA——
ECHA——

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter levothyroxine

  • thyroid hormone replacement medications
  • Hashimoto's disease treatment
  • hypothyroidism therapy

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Levothyroxine:

  • Liothyronine (T3) for T3-specific indications
    Trade-offs: Shorter half-life requires multiple daily doses. Cardiac arrhythmia risk higher. Not a true substitute — different hormone.
    Relative cost: Similar
  • Desiccated thyroid (Armour Thyroid)
    Trade-offs: Variable T3:T4 ratio. Batch inconsistency. Some patients prefer, but ATA recommends levothyroxine.
    Relative cost: 1.5-2×

Frequently asked questions

What products contain levothyroxine?

Levothyroxine appears in: thyroid hormone replacement medications; Hashimoto's disease treatment; hypothyroidism therapy.

See Levothyroxine in the baby app

Look up products containing levothyroxine, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. ATSDR Toxicological Profile — CAS 51-48-9 — reference

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →